FDA NDC Directory · JSON-LD · Markdown

Revuforj

NDC 73555-502 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Generic namerevumenib
Labeler / ManufacturerSyndax Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA218944
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsREVUMENIB CITRATE (160 mg/1)
Marketing started20241115
Package count1

External sources

Source: openFDA. Public-domain (CC0).